Latest formulary decision guides
-
Formulary decision guideNutramigen™ PURAMINO™
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mead Johnson Nutrition Ltd in a format developed by Guidelines in Practice . Key points Cow’s milk allergy (CMA) is a common yet complex food allergy, ...
-
Formulary decision guide
Methofill® (methotrexate) Self Inject
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Accord UK Ltd in a format developed by Guidelines in Practice . View prescribing and adverse event reporting information here Key points Methofill ® ...
-
Formulary decision guide
Formulary decision guide: Trajenta® (linagliptin) 5 mg film-coated tablets
Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance
-
Formulary decision guide
Semglee® ▼ (insulin glargine biosimilar)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice. View prescribing information here Key points
-
Formulary decision guide
Spiriva® Respimat® (tiotropium)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Boehringer Ingelheim Limited in a format developed by Guidelines in Practice . Boehringer Ingelheim Limited reviewed the content for compliance with the ABPI code of practice. View prescribing information here ...
-
Formulary decision guide
Formulary decision guide: Ozempic®▼ (semaglutide)
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Novo Nordisk in a format developed by Guidelines in Practice. It has been reviewed by Novo Nordisk, who commissioned the development of the formulary decision guide. Download the formulary decision guide ...
-
Formulary decision guide
Formulary decision guide: Hulio® ▼ (adalimumab biosimilar)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice. It has been reviewed by a medicines management professional. View prescribing information here
-
Formulary decision guide
Formulary decision guide: Peptac® (sodium bicarbonate, sodium alginate, calcium carbonate)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Teva UK Limited in a format developed by Guidelines in Practice . It has been reviewed by a medicines management professional. Click here to visit the Teva Spotlight resource hub Download ...
-
Formulary decision guide
Formulary decision guide: Sondate® XL (quetiapine fumarate) prolonged-release tablets
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Teva UK Limited in a format developed by Guidelines in Practice. It has been reviewed by a member of the Guidelines in Practice editorial board. Click here to visit the Teva
-
Formulary decision guide
Formulary decision guide: Monomil® XL (isosorbide mononitrate) prolonged release tablets
Information intended for healthcare professionals only. This formulary decision guide was developed from content supplied by Teva UK Limited in a format developed by Guidelines in Practice. Prescribing information can be found on page 2 of the formulary decision guide. Click here to visit the Teva
